Between June 1 and December 26, 2024, 3,538 outbreaks of Epizootic Hemorrhagic Disease (EHD) were recorded in France on farms.
The departments affected by the MHE since June 1, 2024 are: Haute-Garonne, Gers, Pyrénées-Atlantiques, Hautes-Pyrénées, Landes, Maine-et-Loire, Pyrénées-Orientales, Ariège, Dordogne, Tarn, Tarn-et-Garonne , Aude, Aveyron, Loire-Atlantique, Lot, Lot-et-Garonne, Hérault, Vendée, Vienne, Indre-et-Loire, Sarthe, Cantal, Charente, Charente-Maritime, Creuse, Cher, Lozère, Morbihan, Ille-et-Vilaine, Mayenne.
Vaccination strategy
A vaccine against MHE obtained temporary authorization for use, for France, on August 6, 2024. The first doses of vaccine were made available on September 23.
The State set up a vaccination zone from September 18, 2024 in order to limit the spread of the disease towards the east of France by creating a vaccination band all along the limit of the regulated zone. Several Lozère municipalities were then concerned. Since December 13, all Lozère breeders have been eligible for the vaccine.
Read also
MHE is gaining ground in Lozère
Epizootic hemorrhagic disease (EHD), a new health threat
